In inflammatory demyelinating diseases such as multiple sclerosis and experimental allergic encephalomyelitis, myelin destruction occurs in the vicinity of infiltrating mononuclear cells. The observations that myelin can be altered prior to phagocytosis and in areas not contiguous with inflammatory cells suggests a common mechanism for the initial stages of demyelination. Because stimulated macrophages secrete several neutral proteases, including plasminogen activator, we have investigated the possibility that myelinolysis could be mediated directly or indirectly by these enzymes. Isolated myelin was incubated with conditioned media from cultures of thioglycollate-stimulated mouse peritoneal macrophages in the presence and absence of plasminogen. Myelin appeared to be vulnerable to attack by at least two proteolytic activities secreted by the macrophages, a plasminogen-dependent and a plasminogen-independent activity; of the major proteins in myelin, the basic protein was most susceptible. The direct myelinolytic activity of macrophage-conditioned media was abolished by EDTA, and the plasminogen-dependent hydrolysis was abolished by p-nitrophenylguanidinobenzoate, an inhibitor of plasminogen activator and plasmin. These results suggest that the plasminogen activator released by the stimulated macrophages generated plasmin which hydrolyzed basic protein in intact myelin. This interpretation was confirmed by the observation that urokinase, a plasminogen activator, in the presence of plasminogen brought about marked degradation of basic protein in myelin. We propose that the release of neutral proteases by stimulated macrophages involved in cell-mediated reactions, and its amplification by the plasminogen-plasmin system, may play a significant role in the demyelination observed in several inflammatory demyelinating diseases.
served in several inflammatory demyelinating diseases. The classification "demyelinating diseases" is now reserved by most neuropathologists and neurologists exclusively for the acquired inflammatory diseases of myelin in which there is loss of myelin with sparing of axons (1, 2) . The most extensively studied disorders in this category are multiple sclerosis (MS) and the model disease, experimental allergic encephalomyelitis (EAE). These diseases are characterized by perivascular infiltration of hematogenous cells in association with areas of demyelination (1, 2) .
Lesion formation in inflammatory demyelinating diseases is generally believed to be related to an immunological response, either autoimmune or the result of a viral infection. However, the mechanism by which the inflammatory cells, predominantly macrophages and lymphocytes in MS and EAE, participate in the process of demyelination has not yet been defined. Most attention has been directed toward acid proteases and lysosomal hydrolases which increase in and around MS plaques (3) (4) (5) (6) (7) (8) (9) and in lesions in animals with EAE (10) (11) (12) (13) (14) (15) . It has
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been established that mouse peritoneal macrophages stimulated by thioglycollate broth or by products of activated lymphocytes secrete several neutral proteases (16) (17) (18) (19) , including plasminogen (Plg) activator (20) (21) (22) (23) (24) 18) . Such extracellular proteases generated from macrophages activated as a consequence of a reaction of sensitized T-lymphocytes with antigen, if capable of degrading myelin proteins, could initiate a process of myelin destruction common to inflammatory and cell-mediated immune reactions occurring in nervous tissue. We have investigated the feasibility of such a mechanism, by studying the proteolytic activity of products of activated macrophages on purified myelin.
MATERIALS AND METHODS
Reagents. Materials were obtained from the following suppliers: porcine Plg, Sigma Chemical Co., St (30) . Fig. 1 gives a qualitative indication of the changes occurring in the protein pattern on NaDodSO4/polyacrylamide gels of myelin that had been incubated alone or with conditioned medium from stimulated macrophages in the presence or absence of P1g. After incubation of the myelin with macrophage supernatant alone (gel 3), the band for BP diminished significantly compared to myelin incubated without enzymes (gel 1). Incubation with supernatant plus Plg gave greater breakdown of BP (gel 4) than occurred with the supernatant alone (gel 3). Incubation with purified Plg along (gel 2) had little effect. Faint stained bands of degradation products can be seen below the BP band in gels 3 and 4.
Quantitative differences among the protein bands on stained gels became more obvious in the densitometric scans of gels from another experiment (Fig. 2) . Macrophage-conditioned medium had the ability to cause some degradation (39% in this experiment) of BP directly (curve b), and this observation was consistent with subsequent findings, suggesting that BP was vulnerable to attack by neutral proteases in the macrophageconditioned media. In the presence of unpurified Pig alone (curve c), 23% of the BP was degraded. However, preferential loss of BP was most dramatic when both Pig and conditioned medium were present (curve d; 77% BP degraded), suggesting that the macrophages were secreting a Pig activator (20, 22, Plg-dependent and Plg-independent degradation of BP in myelin by supernatants from resting and thioglycollate-stimulated peritoneal macrophages. Unstimulated (U) and thioglycollate-stimulated (T) macrophages were cultivated for 2 days before preparation of conditioned medium in Dulbecco's medium plus 0.1% lactalbumin hydrolysate. UA, UB, TA, and TB were collected at 2 days; U1 and T1 and U2 and T2 were consecutive 3-and 4-day collections. One hundred microliters of reconstituted conditioned medium represented the product of 2 X 106 macrophages and contained fibrinolytic activity as follows: U1 and U2, 2.3-4.2 units for Plg-dependent and -independent activity; T1 and T2, 176 and 85 units for Plg-dependent and 14 and 6.4 units for Plg-independent activity, respectively. The data from various experiments, similar to those illustrated in Fig. 4 suspension than of fibrin monolayers to both Plg-dependent and Pig-independent proteolytic activities: whereas the fibrinolytic data show a large difference between supernatants from stimulated and unstimulated cells, the differences in myelinolysis (comparing U1 and U2 to T1 and T2) are less striking.
Use of Inhibitors to Distinguish between Plg Activator and Other Neutral Proteases. The observation of neutral protease activity in macrophage-conditioned media capable of degrading BP in the absence as well as the presence of Pig suggested that the degradation of myelin was effected by more than one proteolytic enzyme. NPGB, a specific inhibitor of both Pig activator and plasmin (18) , and EDTA, which inhibits other macrophage-secreted neutral proteases (18) , were used to assess the relative contributions of the Plg-dependent and -independent mechanisms. The Plg-independent breakdown of BP in myelin was markedly inhibited by the presence of EDTA (Fig.  5) . However, when Pig was added to conditioned media in the presence of EDTA, the Pig-dependent degradation of BP was found to be unaffected, remaining comparable to the Pigdependent increment produced in the absence of inhibitors. Conversely, NPGB substantially decreased the Plg-dependent increment in BP degradation, whereas the direct proteolytic activity of the macrophage-conditioned medium alone was not affected. The simultaneous addition of both NPGB and EDTA virtually abolished BP degradation by macrophage-conditioned medium in the presence or absence of Pig. The degradation of BP in myelin by Plg-dependent as well as EDTA-sensitive neutral proteases secreted by stimulated macrophages was consistently found in experiment with nine preparations of conditioned media prepared by two separate laboratories. Furthermore, macrophage supernatants plus Pig were effective in degrading BP in brain myelin prepared from the three species tested-cow, cat, and rabbit. In additional experiments, purified BP isolated from myelin was found also to be sensitive to proteolytic degradation by macrophage-conditioned medi- (20) (21) (22) (23) , collagenase (16, 19, 31) , and elastase (17) . Although the Plg-independent myelinolysis may have been produced directly by one of these proteases, the possible sequential activation of latent enzymes by macrophage-secreted enzymes, as has been demonstrated for a latent collagenase (32) , precludes certain identification of the Plg-independent protease activity. There was a general parallel between Plg-dependent fibrinolytic and myelinolytic activities, but there were occasional quantitative discrepancies in the levels of the two activities that might be related to time of collection of the conditioned media and differences in sensitivity of the two assays.
In previous studies the secretion of macrophage neutral proteases has been related to the state of activation of the cells. Stimulation of macrophages by thioglycollate (16, 17, 20) , priming with endotoxin and challenge with latex particles (21), or immunologic sensitization and challenge (33) (34) (35) result in macrophages that secrete greater levels of neutral proteases. These findings have been confirmed as well in the myelinolytic system, where thioglycollate-induced macrophages produced 3-6 times more proteolytic activity than did unstimulated cells. However, the myelinolytic assay is so sensitive that even uninduced macrophage-conditioned media contain easily demonstrable protease activity.
Because of the predominance of macrophages in lesions of inflammatory demyelinating disease such as MS and EAE, it has been suspected that such cells may be involved in degradation of myelin as well as in the final clearance of myelin debris by phagocytosis. Many studies have shown that acid proteases and other lysosomal enzymes are increased around active MS plaques (3-9, 36, 37) and in the central nervous system in EAE (10) (11) (12) (13) (14) (15) . The increase in acid proteases in plaques correlates with the decrease in BP (5, 6) which is known to be readily digested by proteases (13, 38, 39) . However, neutral and acid protease activities were elevated to a similar degree in the spinal cord of rats with EAE (40).
We believe that secreted neutral proteases are likely to be a more significant factor than lysosomal enzymes in early stages of demyelination for several reasons. In morphologic studies of MS and EAE, disruption of myelin is seen to occur prior to identifiable phagocytosis. In EAE, macrophages can be seen penetrating and stripping the myelin lamellae (41, 42) , and extensive vesicular disruptions of the sheath are commonly seen in the vicinity of mononuclear cells (41, 43, 44) . A similar morphological picture is seen in the early stages of demyelination occurring as a "bystander effect" to a delayed hypersensitivity reaction to nonbrain antigens occurring in the vicinity of myelinated fibers (45, 46) . In MS, macrophages are not seen engaged in active stripping of myelin from axons; rather, the early changes are disintegration of the sheath into lamellar and granular debris (47, 48) . These observations support the view that the proteases act extracellularly. The level of activity of lysosomal hydrolases, if released extracellularly, is likely to be low because they are relatively inactive at physiologic pH.
A mechanism for extracellular degradation of myelin would predict the finding of myelin deficient in BP in lesions and the occurrence of myelin fragments in the cerebrospinal fluid of patients undergoing inflammatory demyelination. Both phenomena have been reported in MS. A decreased content of BP in MS myelin has been reported (49, 50) and was more pronounced in myelin isolated from plaques than from normalappearing white matter (48) . Recent studies show that there is serologically detectable BP-like material in the cerebrospinal fluid of MS patients and that the amount of BP or its fragments assayed by radioimmunoassay correlates with the clinical stage of the disease (51, 52) . Of particular significance for the present studies are the data that show that the antigen in cerebrospinal fluid may not be intact BP but rather a fragment of it (52) .
A model for inflammatory demyelination consistent with the present and previous observations would propose that sensitized lymphocytes, with specificity either for exogenous antigens (such as viruses) or for brain antigens in the case of EAE are activated by those antigens in the vicinity of myelinated fibers. As a consequence, products of activated lymphocytes are secreted which both increase chemotaxis for mononuclear cells and activate the macrophages attracted to the site to secrete neutral proteases. Some macrophage-secreted proteases might act to degrade myelin directly where there is close contact. A second aspect of the mechanism would be the amplification of the macrophage-produced proteolytic activities by interaction with zymogens, such as Plg, present in serum and tissue spaces. Plasminogen serves as an enormous reservoir in serum of potential proteolytic activity which could be activated locally to plasmin by Plg activator secreted by activated macrophages. Although serum proteins are normally excluded from the nervous system, Plg would be freely available to the brain parenchyma in any situation in which the blood/brain barrier is damaged, which is known to occur in inflammatory reactions.
The amount of protease generated from Plg could be sufficient to overcome the high levels of natural protease inhibitors. The relative specificity of these reactions for causing demyelination Medical Sciences: Carnmer et al.
would lie in the remarkable vulnerability of myelin BP to proteases, which has been amply documented (38, and which we have further demonstrated here. Although plasmin has been shown here to be capable of degrading BP in myelin, it is a key enzyme in a number of cascade systems including the coagulation and complement systems and thus could be involved in further amplifying both the inflammatory and the proteolytic components of such reactions.
The mechanism of demyelination initiated by-macrophage-secreted proteases proposed here suggests several strategies for intervention to decrease the degree of demyelination. If demyelination is caused by one or more extracellular pro-*teases, then inhibitors of these enzyme activities, currently available or to be developed, offer the possibility of limiting the extent of demyelination. In addition, secretion of Plg activator by activated macrophages is known to be markedly inhibited by dexamethasone and inducers of cyclic AMP (23) . Thus, the extent of demyelination might be restricted by pharmacologic agents that control enzyme secretion by these cells. Further studies of inhibitors of macrophage protease production and activity will be of importance both for more clear definition of the mechanisms underlying demyelination in vivo and to provide new ways to control these processes.
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